NOTCH1 and acute lymphoblastic leukemia: Differently from T-ALL, NOTCH1 mutations clustered uniquely in the PEST domain and the 2-bp frameshift deletion (ΔCT7544–7545, P2515fs) is present in about 80% of cases, making it a potential target for screening and specific targeted therapies.